Susquehanna International Group, LLP Catalyst Pharmaceuticals, Inc. Put Options Transaction History

Susquehanna International Group, LLP

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2023 Aug 11, 2023	BUY	$11.5 - $18.08 $136,850 - $215,151	11,900 Added 79.33%	26,900 $361,000
Q1 2023 May 16, 2023	BUY	$14.34 - $21.05 $35,850 - $52,625	2,500 Added 20.0%	15,000 $248,000
Q4 2022 Feb 14, 2023	SELL	$12.25 - $19.5 $90,650 - $144,300	-7,400 Reduced 37.19%	12,500 $232,000
Q3 2022 Nov 14, 2022	BUY	$7.06 - $15.52 $140,494 - $308,848	19,900 New	19,900 $255,000

285

96.6M

29.2K

20.5K

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.04B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.